The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Autotaxin Stabilizes Blood Vessels and Is Required for Embryonic Vasculature by Producing Lysophosphatidic Acid
Open accessAbstract
Autotaxin (ATX) is a cancer-associated motogen that has multiple biological activities in vitro through the production of bioactive small lipids, lysophosphatidic acid (LPA). ATX and LPA are abundantly present in circulating blood. However, their roles in circulation remain to be solved. To uncover the physiological role of ATX we analyzed ATX knock-out mice. In ATX-null embryos, early blood vessels appeared to form properly, but they failed to develop into mature vessels. As a result ATX-null mice are lethal around embryonic day 10.5. The phenotype is much more severe than those of LPA receptor knock-out mice reported so far. In cultured allantois explants, neither ATX nor LPA was angiogenic. However, both of them helped to maintain preformed vessels by preventing disassembly of the vessels that was not antagonized by Ki16425, an LPA receptor antagonist. In serum from heterozygous mice both lysophospholipase D activity and LPA level were about half of those from wild-type mice, showing that ATX is responsible for the bulk of LPA production in serum. The present study revealed a previously unassigned role of ATX in stabilizing vessels through novel LPA signaling pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
The emerging role of lysophosphatidic acid in cancer
Mills, G. B., & Moolenaar, W. H. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1143 · Cited by 1,094
Umezu-Goto, M., Kishi, Y., Taira, A., Hama, K., Dohmae, N., Takio, K., Yamori, T., Mills, G. B., Inoue, K., Aoki, J., et al. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200204026 · Cited by 929
Self-citationLysophospholipid Receptors: Signaling and Biology
Ishii, I., Fukushima, N., Ye, X., & Chun, J. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073731 · Cited by 771
Essential Role for Sphingosine Kinases in Neural and Vascular Development
Mizugishi, K., Yamashita, T., Olivera, A., Miller, G. F., Spiegel, S., & Proia, R. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.11113-11121.2005 · Cited by 742
Tokumura, A., Majima, E., Kariya, Y., Tominaga, K., Kogure, K., Yasuda, K., & Fukuzawa, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205623200 · Cited by 731
Stracke, M. L., Krutzsch, H. C., Unsworth, E. J., Arestad, A., Cioce, V, Schiffmann, E., & Liotta, L. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45911-x · Cited by 590
LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing
Ye, X., Hama, K., Contos, J. J. A., Anliker, B., Inoue, A., Skinner, M. K., Suzuki, H., Amano, T., Kennedy, G., Arai, H., et al. (2005) · Nature · doi:10.1038/nature03505 · Cited by 562
Self-citationNoguchi, K., Ishii, S., & Shimizu, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302648200 · Cited by 557
Requirement for the lp A1 lysophosphatidic acid receptor gene in normal suckling behavior
Contos, J. J. A., Fukushima, N., Weiner, J. A., Kaushal, D., & Chun, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13384 · Cited by 479
GPR92 as a New G12/13- and Gq-coupled Lysophosphatidic Acid Receptor That Increases cAMP, LPA5
Lee, C.-W., Rivera, R., Gardell, S., Dubin, A. E., & Chun, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603670200 · Cited by 471
Mice Deficient in Sphingosine Kinase 1 Are Rendered Lymphopenic by FTY720
Allende, M. L., Sasaki, T., Kawai, H., Olivera, A., Mi, Y., van Echten-Deckert, G., Hajdu, R., Rosenbach, M., Keohane, C. A., Mandala, S., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406512200 · Cited by 447
Serum Lysophosphatidic Acid Is Produced through Diverse Phospholipase Pathways
Aoki, J., Taira, A., Takanezawa, Y., Kishi, Y., Hama, K., Kishimoto, T., Mizuno, K., Saku, K., Taguchi, R., & Arai, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206812200 · Cited by 429
Self-citationKono, M., Mi, Y., Liu, Y., Sasaki, T., Allende, M. L., Wu, Y.-P., Yamashita, T., & Proia, R. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403937200 · Cited by 415
Ki16425, a Subtype-Selective Antagonist for EDG-Family Lysophosphatidic Acid Receptors
Ohta, H., Sato, K., Murata, N., Damirin, A., Malchinkhuu, E., Kon, J., Kimura, T., Tobo, M., Yamazaki, Y., Watanabe, T., et al. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.4.994 · Cited by 402
Contos, J. J. A., Ishii, I., Fukushima, N., Kingsbury, M. A., Ye, X., Kawamura, S., Brown, J. H., & Chun, J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.19.6921-6929.2002 · Cited by 316
Mechanisms of lysophosphatidic acid production
Aoki, J. (2004) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2004.05.001 · Cited by 305
Self-citationHama, K., Aoki, J., Fukaya, M., Kishi, Y., Sakai, T., Suzuki, R., Ohta, H., Yamori, T., Watanabe, M., Chun, J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313927200 · Cited by 276
Self-citationKishi, Y., Okudaira, S., Tanaka, M., Hama, K., Shida, D., Kitayama, J., Yamori, T., Aoki, J., Fujimaki, T., & Arai, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601803200 · Cited by 244
Self-citationKotarsky, K., Boketoft, Å., Bristulf, J., Nilsson, N. E., Norberg, Å., Hansson, S., Owman, C., Sillard, R., Leeb-Lundberg, L. M. F., & Olde, B. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.098848 · Cited by 237
Clair, T., Aoki, J., Koh, E., Bandle, R., Nam, S. W., Ptaszynska, M. M., Mills, G. B., Schiffmann, E., Liotta, L. A., & Stracke, M. L. (2003) · PubMed · Cited by 222
Self-citationSphingosine Kinase 2 Is Required for Modulation of Lymphocyte Traffic by FTY720
Kharel, Y., Lee, S., Snyder, A. H., Sheasley-O'Neill, S. L., Morris, M. A., Setiady, Y., Zhu, R., Zigler, M. A., Burcin, T. L., Ley, K., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506293200 · Cited by 210
Iseki, S., Wilkie, A. O. M., Heath, J. K., Ishimaru, T., Eto, K., & Morriss-Kay, G. M. (1997) · Development · doi:10.1242/dev.124.17.3375 · Cited by 207
Self-citationAutotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor.
Nam, S. W., Clair, T., Kim, Y. S., McMarlin, A., Schiffmann, E., Liotta, L. A., & Stracke, M. L. (2001) · PubMed · Cited by 195
Nam, S. W., Clair, T., Campo, C. K., Lee, H. Y., Liotta, L. A., & Stracke, M. L. (2000) · Oncogene · doi:10.1038/sj.onc.1203263 · Cited by 187
Takuwa, Y. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00145-2 · Cited by 173
Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells
Yang, S. Y., Lee, J., Park, C. G., Kim, S., Hong, S., Chung, H. C., Min, S. K., Han, J. W., Lee, H. W., & Lee, H. Y. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1020950420196 · Cited by 161
Stassar, M. J. J. G., Devitt, G., Brosius, M., Rinnab, L. J., Prang, J., SCHRADIN, T., Simon, J., Petersen, S., Kopp‐Schneider, A., & Zöller, M. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2074 · Cited by 158
Baumforth, K. R. N., Flavell, J. R., Reynolds, G. M., Davies, G., Pettitt, T. R., Wei, W., Morgan, S. L., Stankovic, T., Kishi, Y., Arai, H., et al. (2005) · Blood · doi:10.1182/blood-2005-02-0471 · Cited by 118
Self-citationExpression, regulation and function of autotaxin in thyroid carcinomas
Kehlen, A., Englert, N., Seifert, A., Klonisch, T. C., Dralle, H., Langner, J., & Hoang‐Vu, C. (2004) · International Journal of Cancer · doi:10.1002/ijc.20022 · Cited by 112
Euer, N., Schwirzke, M., Evtimova, V., BURTSCHER, H. J., Jarsch, M., Tarin, D., & Weidle, U. H. (2002) · PubMed · Cited by 104
Ruwisch, L., Schäfer-Korting, M., & Kleuser, B. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000365 · Cited by 68
VEGF signaling is required for the assembly but not the maintenance of embryonic blood vessels
Argraves, W. S., LaRue, A. C., Fleming, P. A., & Drake, C. J. (2002) · Developmental Dynamics · doi:10.1002/dvdy.10162 · Cited by 39
Cited by
The Hippo pathway and human cancer
Harvey, K. F., Zhang, X., & Thomas, D. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3458 · Cited by 1,842
A Computational Tool for Quantitative Analysis of Vascular Networks
Zudaire, E., Gambardella, L., Kurcz, C., & Vermeren, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027385 · Cited by 1,085
Cellular function and molecular structure of ecto-nucleotidases
Zimmermann, H., Zebisch, M., & Sträter, N. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9309-4 · Cited by 977
LPA Receptors: Subtypes and Biological Actions
Choi, J. W., Herr, D. R., Noguchi, K., Yung, Y. C., Lee, C.-W., Mutoh, T., Lin, M.-E., Teo, S. T., Park, K. E., Mosley, A. N., et al. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105753 · Cited by 839
An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases
Law, S.-H., Chan, M.-L., Marathe, G. K., Parveen, F., Chen, C.-H., & Ke, L.-Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051149 · Cited by 817
Metadata
- Authors
- Tanaka, M., Okudaira, S., Kishi, Y., Ohkawa, R., Iseki, S., Ota, M., Noji, S., Yatomi, Y., Aoki, J., & Arai, H.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 281
- Issue
- 35
- Pages
- 25822-25830
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2010110193
- Cited by
- 457
- References
- 34
- FWCI
- 10.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.